Medical Director, UCH Clinical Microbiology Laboratory
Recognition & Awards
Savin award, Dept of Pathology, UCD
(2010)
Excellence in Teaching
Excellence in Education Administration, Academy of Medical Educators, UCD
(2009)
Research Interests
My principal activities are Medical Director of the Clinical Microbiology Laboratory for University of Colorado Hospital, teaching and patient care. I participate in a number of studies which involve antimicrobial resistance surveys, new diagnostic methods, molecular epidemiology for outbreak investigations at UCH, and clinical studies of new antimicrobial agents. I am actively involved in the HIV primary care program at UCH and have interests in transplant infectious diseases and international health.
Publications
Goodman A, Patten L, Castillo-Mancilla J, Zimmer S, Madinger N, Frasca K. Factors Associated with Retention and Adherence in a Comprehensive, Diverse HIV Pre-Exposure Prophylaxis Clinic. AIDS Res Hum Retroviruses. 2022 Jan 6. [Epub ahead of print] PubMed PMID: 34861765
Eller KA, Aunins TR, Courtney CM, Campos JK, Otoupal PB, Erickson KE, Madinger NE, Chatterjee A. Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria. Commun Biol. 2021 Mar 12;4(1):331. PubMed PMID: 33712689
Mann S, Purohit S, Tobolowsky F, Henao-Martínez A, Bajrovic V, Ramanan P, Wolfel E, Khazanie P, Barron M, Madinger N, Benamu E. Cryptococcal Pericarditis in a Heart Transplant Recipient" Trans Infect Dis. 2020;22(6):e13366
Chatterjee, et al. Facile Accelerated Specific Therapeutic (FAST) Platform Develops Peptide Nucleic Acid Therapies to Counter Multidrug-Resistant Bacteria. CommBio.2021, accepted